pharma · Lower limb spasticity · Pediatric lower limb (LL) spasticity (SP) caused by cerebral palsy (CP)
Merz Therapeutics
Merz Pharmaceuticals GmbH
Merz Therapeutics clinical programs — 2 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
frankfurt am main, DE HQ
2020 Founded
1,312 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- frankfurt am main, DE
- Founded
- 2020
- Employees
- 1,312
- Programs
- 2
- Drugs
- 4
- Patents
- 0
Merz Therapeutics projects
2 ClinicalTrials.gov programs sponsored by Merz Therapeutics.
Merz Therapeutics has 2 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
Frequently asked questions
How many clinical projects does Merz Therapeutics have?
2 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.